Dong L-H, Li L, Song Y, Duan Z-L, Sun S-G, Lin Y-L, et al
The annual incidence of DILI in the general population is approximately 15--20 per 100,000 people, although this may be an underestimate
Tirzepatide: This is a dual GIP/GLP-1 receptor agonist
The reason BDF promotes the expression of antioxidant factors still needs further exploration
Edited by Zhi-Xiong Xiao Rights and permissions Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made